These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 30855105)

  • 1. Ironing out the Brain.
    Ward RJ; Crichton RR
    Met Ions Life Sci; 2019 Jan; 19():. PubMed ID: 30855105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurodegenerative diseases and therapeutic strategies using iron chelators.
    Ward RJ; Dexter DT; Crichton RR
    J Trace Elem Med Biol; 2015; 31():267-73. PubMed ID: 25716300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulation of glutathione homeostasis in neurodegenerative diseases.
    Johnson WM; Wilson-Delfosse AL; Mieyal JJ
    Nutrients; 2012 Oct; 4(10):1399-440. PubMed ID: 23201762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conservative iron chelation for neurodegenerative diseases such as Parkinson's disease and amyotrophic lateral sclerosis.
    Devos D; Cabantchik ZI; Moreau C; Danel V; Mahoney-Sanchez L; Bouchaoui H; Gouel F; Rolland AS; Duce JA; Devedjian JC;
    J Neural Transm (Vienna); 2020 Feb; 127(2):189-203. PubMed ID: 31912279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics.
    Belaidi AA; Bush AI
    J Neurochem; 2016 Oct; 139 Suppl 1():179-197. PubMed ID: 26545340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostics and Treatments of Iron-Related CNS Diseases.
    Xiong H; Tuo QZ; Guo YJ; Lei P
    Adv Exp Med Biol; 2019; 1173():179-194. PubMed ID: 31456211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miRNAs as biomarkers of neurodegenerative disorders.
    Viswambharan V; Thanseem I; Vasu MM; Poovathinal SA; Anitha A
    Biomark Med; 2017 Feb; 11(2):151-167. PubMed ID: 28125293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28.
    Youdim MB; Stephenson G; Ben Shachar D
    Ann N Y Acad Sci; 2004 Mar; 1012():306-25. PubMed ID: 15105275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron chelation in the treatment of neurodegenerative diseases.
    Dusek P; Schneider SA; Aaseth J
    J Trace Elem Med Biol; 2016 Dec; 38():81-92. PubMed ID: 27033472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transition metals copper and iron in neurodegenerative diseases.
    Rivera-Mancía S; Pérez-Neri I; Ríos C; Tristán-López L; Rivera-Espinosa L; Montes S
    Chem Biol Interact; 2010 Jul; 186(2):184-99. PubMed ID: 20399203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepcidin and its therapeutic potential in neurodegenerative disorders.
    Qian ZM; Ke Y
    Med Res Rev; 2020 Mar; 40(2):633-653. PubMed ID: 31471929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological metals and metal-targeting compounds in major neurodegenerative diseases.
    Barnham KJ; Bush AI
    Chem Soc Rev; 2014 Oct; 43(19):6727-49. PubMed ID: 25099276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chelating agents for neurodegenerative diseases.
    Ward RJ; Dexter DT; Crichton RR
    Curr Med Chem; 2012; 19(17):2760-72. PubMed ID: 22489724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular Mechanisms of Melatonin: Insight from Neurodegenerative Diseases.
    Chen D; Zhang T; Lee TH
    Biomolecules; 2020 Aug; 10(8):. PubMed ID: 32784556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity of biophysical and biochemical alterations in erythrocyte membranes in neurological disorders--Huntington's disease, Friedreich's ataxia, Alzheimer's disease, amyotrophic lateral sclerosis, and myotonic and duchenne muscular dystrophy.
    Butterfield DA; Markesbery WR
    J Neurol Sci; 1980 Aug; 47(2):261-71. PubMed ID: 6251175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innate Immunity and Neurodegeneration.
    Labzin LI; Heneka MT; Latz E
    Annu Rev Med; 2018 Jan; 69():437-449. PubMed ID: 29106805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting mitochondrial metal dyshomeostasis for the treatment of neurodegeneration.
    Liddell JR
    Neurodegener Dis Manag; 2015 Aug; 5(4):345-64. PubMed ID: 26295717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview.
    Mariani E; Polidori MC; Cherubini A; Mecocci P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Nov; 827(1):65-75. PubMed ID: 16183338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Potential of Flavonoids for the Treatment of Neurodegenerative Diseases.
    Maher P
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31234550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.